TMCI Investors with Losses in Excess of $100K Have Opportunity to Lead Treace Medical Concepts, Inc. Securities Fraud Lawsuit

Core Viewpoint - A class action lawsuit has been filed against Treace Medical Concepts, Inc. for alleged misleading statements and failure to disclose critical information regarding its primary product, the Lapiplasty 3D Bunion Correction System, impacting investor decisions during the specified Class Period [1][5]. Group 1: Lawsuit Details - The class action lawsuit is on behalf of purchasers of Treace Medical securities between May 8, 2023, and May 7, 2024 [1]. - Allegations include that competition affected the demand for the Lapiplasty system, leading to a decline in revenue and necessitating an accelerated product development plan [5]. - The lawsuit claims that the defendants made materially misleading statements about the company's business and prospects, resulting in investor damages when the truth was revealed [5]. Group 2: Participation Information - Investors who purchased Treace Medical securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested parties can join the class action by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must file a motion with the court by June 10, 2025, to represent other class members [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field [4]. - The firm has recovered hundreds of millions of dollars for investors, with notable achievements in previous years, including over $438 million in 2019 [4].